(Reuters) – Pfizer Inc and its partner BioNTech said on Thursday that the EU health regulator has recommended authorising the use of their bivalent COVID-19 shot as a booster in children 5 through 11 years of age.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shounak Dasgupta)
